Green Cross Medical Science Corporation (142280) — Cash Flow Reinvestment Rate
Green Cross Medical Science Corporation (142280) has a Cash Flow Reinvestment Rate of 0.09x as of December 2025, reinvesting ₩460.89 Million (capex ₩460.89 Million ) from operating cash flow of ₩5.01 Billion. See 142280 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Green Cross Medical Science Corporation Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Green Cross Medical Science Corporation across 6 annual periods. For the full cash flow conversion analysis, see Green Cross Medical Science Corporation (142280) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Green Cross Medical Science Corporation (2016–2025)
Year-by-year capital reinvestment analysis for Green Cross Medical Science Corporation. See Green Cross Medical Science Corporation (142280) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | ₩4.90 Billion | ₩7.20 Billion | ₩4.90 Billion | ▼ -61.5% |
| 2024 | 1.77x | ₩6.47 Billion | ₩3.66 Billion | ₩3.22 Billion | ▼ -20.7% |
| 2023 | 2.23x | ₩9.45 Billion | ₩4.24 Billion | ₩5.63 Billion | ▲ +311.2% |
| 2022 | 0.54x | ₩5.90 Billion | ₩10.88 Billion | ₩3.43 Billion | ▼ -0.8% |
| 2017 | 0.55x | ₩1.70 Billion | ₩3.11 Billion | ₩1.11 Billion | ▲ +106.8% |
| 2016 | 0.26x | ₩2.71 Billion | ₩10.25 Billion | ₩1.89 Billion | — |